A custom cited dossier on the target you're building around.
You name the target, mechanism, or disease area. Researched and written with expert scientific review — every citation is verified against the primary literature before the report ships. That verification is why turnaround is 24 hours instead of instant. The report covers the biology, disease-relevant pathways, preclinical and translational evidence, and the therapeutic considerations a real drug-development team needs to think through.
Every Target Intelligence Report is built to a single, deliberate structure — the same structure used in a real report we've already shipped. It isn't a template with your target's name find-and-replaced in. Each section is written from the primary literature on the target you named, in the indications that matter for your program.
The structure below is the actual outline of a delivered report (~20+ pages of substantive analysis, not filler). It's what we produce every time.
Executive Summary
The core finding and why it matters, stated up front — no throat-clearing.
Target / Mechanism Biology
Structure, expression, activation, and upstream / downstream signaling for the target you named.
Disease-Relevant Pathway Analysis
How the target actually connects to the disease biology in the indications that matter for your program.
Preclinical Evidence by Indication
Organized disease-by-disease — not one undifferentiated literature dump. Each indication gets its own subsection with the evidence that supports (or complicates) it.
Clinical & Translational Evidence
What has actually been shown in humans, or in translational models — where the evidence exists, and where it doesn't.
Integrated Pathway Map
The full mechanistic cascade in one place, so the biology and the therapeutic hypothesis line up on a single diagram.
Therapeutic Considerations & Optimization Strategies
What a real drug-development team would need to think about next — selectivity, resistance, PK/PD, patient selection, competing programs.
Future Directions & Emerging Opportunities
Where the field is actually headed — nascent modalities, adjacent indications, and the specific questions worth funding next.
Key Literature & Evidence Summary
The citations that matter, organized by theme and weight of evidence — not a raw bibliography dump at the end.
Glossary / Appendix
So the report is usable by collaborators, reviewers, and non-specialists on your team — not just the immediate specialty.
Custom to your target, not a template
You name the target, mechanism, or disease area after purchase. Every section is written to that specific scope — not adapted from a generic dossier.
Expert-reviewed, citations verified
Researched and written with expert scientific review — every citation is verified against the primary literature before the report ships. That verification is why turnaround is 24 hours instead of instant.
The kind of synthesis that normally takes real research time
Pulling together target biology, disease-specific evidence, translational data, and a real pathway map on a new target is days of work if you do it yourself. This is that write-up, on your desk.
Usable by your whole team
Executive summary up front for the decision-makers, glossary at the back for people outside the immediate specialty. Formatted as a document you can share.
Get it free with an Application Pass.
During the launch window (through Aug 31), the LAUNCH50 Application Pass is $249 (down from $499) and includes one Target Intelligence Report at no extra cost. That's the Deep Score, 90 days of unlimited mock reviews, Winner Intelligence, and the report — $150 less than what buying the report alone plus everything else would run you.
Just want the report? $99.
One custom Target Intelligence Report on the target, mechanism, or disease area you name after checkout. Emailed within 24 hours. No subscription. If you're also planning to submit a grant in the next 90 days, the launch offer on the left is the better deal.
Secure checkout via Stripe. You'll name your target on the next screen.